Technology
Latest News
July 29th 2025
Despite surging GenAI adoption in pharma and the FDA’s recent embrace of the technology, a trust gap remains with GenAI implementations. The story describes four essentials that improve trust in GenAI so that pharma and biotech teams can better navigate the present time of uncertainty.
More News
The Push for a Pull Supply Chain
November 9th 2015In Pharm Exec’s 2013 end-of-year supply chain roundup, we began with a three-word vision of the immediate future that left little room for ambiguity: “Serialization is coming.” With the impending laws regarding “track and trace” promising to alter the way pharmaceuticals are packaged and shipped, we outlined how global pharma was gearing up to deal with the effects of serialization, and how companies needed to review their own internal practices and those of their outsourcing partners, as the need for technology solutions for both sides of the outsourc
Mobilizing for Competitive Success: How Diverse is Your Company’s “V Suite”?
November 3rd 2015Earlier this month, the Get Together Group (G2G) hosted its First Annual Leadership Conference in New Brunswick, NJ. Its goal - to provide mentoring and education to afford members a pathway to the “V-Suite” (Vice President Level).
A New Era in Precision Gene Editing
October 16th 2015Medicine is entering a new era of “gene editing.” Instead of simply being able to “read” our genes, practitioners will be able to adapt and modify DNA sequencing in living cells to treat, cure, and even prevent disease. Defective genes responsible for life-threatening diseases can be rendered harmless by gene editing; it can also be used to develop new, precisely targeted biological drugs based on an individual’s distinct genetic markers. The full list of possibilities, in every area of the life sciences, is simply beyond imagination.
